Browse the evidence

Energy-restricted diets have limited efficacy in reducing body fat and preventing cardiovascular events in T2DM compared to metabolic surgery or newer pharmacological interventions.

While healthy eating is crucial for T2DM, energy-restricted diets alone may not significantly reduce body fat or prevent heart problems in the long term. Combining diet with newer medications that target fat loss may be more effective.

Obesity severity (Class I, II, III) is directly correlated with increased direct medical costs, with Class III obesity costing up to 3.3 times more than normal weight individuals.

Higher obesity classes (II and III) are associated with significantly higher medical costs (up to 3.3x normal weight). This highlights the economic urgency of addressing obesity, especially in higher severity classes, through early intervention.

High host-driven digestibility (HDD) diets, such as ultra-processed foods, decouple host and microbial nutrient status by maximizing small intestinal absorption, which leads to host energy surplus and gut microbial nutrient limitation.

To optimize gut health and metabolic balance, prioritize foods with low host-driven digestibility (high fiber, resistant starch, whole foods). These foods escape small intestinal absorption, reaching the colon to feed beneficial microbes, which in turn produce short-chain fatty acids that support host health. Ultra-processed, high-digestibility foods absorb quickly, leading to host energy surplus and starving the gut microbiome.

Body Mass Index (BMI) is a major confounder in studies linking macronutrient intake to mortality, and its exclusion from multivariate analysis in the PURE study is questionable.

When evaluating studies on diet and health, check if BMI was included as a confounder. Its absence may skew results, as BMI is strongly linked to both diet and mortality.

Short-term feeding studies with fixed energy intake cannot refute the long-term health benefits of a low-glycemic-index (GI) diet because they fail to capture weight-mediated effects and long-term disease progression.

Do not abandon whole grains and low-glycemic foods based on short-term diet studies that force participants to eat the same number of calories. In the real world, low-GI foods often help with satiety and weight management, which are key to preventing diabetes and heart disease. Focus on long-term dietary patterns rich in fiber and whole grains rather than isolated short-term metabolic markers.

Bariatric surgery significantly reduces the incidence of obesity-associated cancers and cancer-specific mortality compared to non-surgical controls.

For individuals with morbid obesity, bariatric surgery is a highly effective intervention for reducing cancer risk. Discuss surgical options with a specialist if lifestyle changes are insufficient.

High cardiorespiratory fitness (CRF) mitigates or eliminates the 'obesity paradox' in heart failure, meaning overweight patients with high CRF do not have better survival than normal-weight patients with low CRF.

For heart failure patients, being overweight is not inherently protective if you are unfit. High cardiorespiratory fitness (CRF) is the key determinant of survival. Focus on improving your fitness through exercise (like the 6-minute walk test or CPX) rather than just focusing on BMI, as high fitness eliminates the 'obesity paradox' survival advantage.

High intake of dietary fructose (common in Western diets) metabolically rewires innate immunity by increasing mTORC1 activity and IL1B expression in monocytes/macrophages, thereby promoting a pro-inflammatory state and reducing metabolic flexibility.

If you consume a diet high in processed foods containing corn syrup or high-fructose ingredients, you may be inadvertently keeping your immune system in a state of low-grade alert. This happens because fructose pushes immune cells to prioritize inflammatory signaling over metabolic flexibility. Reducing processed fructose intake can help restore normal immune metabolic function.

Obesity and the associated accumulation of bone marrow adipocytes disrupt normal hematopoiesis and immune function by creating a pro-inflammatory environment mediated by TLR4 activation, leading to impaired immune responses and increased morbidity/mortality during infections.

Obesity is not just a metabolic issue; it biologically alters your bone marrow environment. Excess fat in the marrow drives chronic inflammation and impairs the production and function of immune cells, making infections more dangerous. Managing weight can help restore normal immune niche function.

Following a 6-month calorie restriction-induced weight loss, resting metabolic rate (RMR) does not significantly adapt (decrease beyond prediction based on body composition), whereas energy expenditure for physical activity (EEPA) significantly decreases, yet neither component's adaptation predicts subsequent weight regain.

Don't fear that your metabolism has permanently slowed down after losing weight. This study shows that while you might move less (lower EEPA), your resting metabolic rate stays proportional to your new body size. More importantly, these metabolic changes didn't predict who would regain weight, suggesting that behavioral factors, not just metabolic adaptation, are key to maintenance.

GLP-1 receptor agonist therapy induces predictable reductions in fat-free mass (approximately 30-40% of total weight loss) due to sustained negative energy balance, not direct catabolic effects.

Expect that about a third of your weight loss on GLP-1s will be muscle/fluid, not just fat. This is normal physiology, not a side effect. To mitigate this, prioritize protein intake and resistance training, especially if you have low testosterone.

Unintentional weight loss is independently associated with increased cardiovascular disease incidence and mortality.

If you are losing weight without trying, see a doctor. It can be a sign of serious health issues that increase your risk of heart disease and death.

Higher body mass index (BMI) causes structural remodeling of the right ventricle, specifically increasing end-diastolic and end-systolic volumes, independent of left ventricular measures.

Maintaining a healthy BMI is crucial for protecting the structure of your right ventricle. This study shows that higher body weight is causally linked to larger heart volumes, which can lead to dysfunction over time. Weight management strategies, including diet and exercise, can help prevent this structural remodeling.

Tirzepatide improves metabolic and inflammatory markers in alcohol-consuming rodents, including reducing body weight, white adipose tissue, hepatic triglycerides, and pro-inflammatory cytokines.

Tirzepatide improves metabolic health and reduces inflammation in alcohol-consuming rodents, potentially addressing comorbidities of AUD.

Higher BMI (Class 2+ obesity, ≥35 kg/m2) is consistently associated with increased odds of mobility, severe mobility, and IADL disability in older adults with type 2 diabetes, regardless of intervention group.

Maintaining a BMI below 35 kg/m2 is crucial for preserving mobility and independence in older adults with type 2 diabetes. While moderate weight loss might not be the primary goal for everyone, avoiding Class 2+ obesity (BMI ≥35) is strongly associated with lower risks of severe mobility and instrumental activities of daily living (IADL) disability.

Bariatric surgery (RYGB, Sleeve Gastrectomy) significantly reduces long-term cardiovascular mortality and incidence of coronary heart disease, stroke, and myocardial infarction compared to non-surgical management.

For severe obesity, bariatric surgery is the most effective long-term treatment for preventing heart attacks, strokes, and death. It works by creating lasting metabolic changes and weight loss.

Long term dietary intake of gluten was not associated with risk of coronary heart disease.

Practitioners should be cautious in promoting gluten-free diets for individuals without celiac disease, as it may not reduce coronary heart disease risk.

Participants in the highest fifth of estimated gluten intake had a multivariable hazard ratio for coronary heart disease of 0.95.

The data suggests that higher gluten intake does not significantly increase coronary heart disease risk, but caution is warranted due to the lack of statistical significance.

A BMI of 25.0 to 29.9 kg/m2 at age 18 years is associated with a hazard ratio of 1.66 for premature death.

BMI categories should be monitored in adolescents for long-term health implications.

Among participants who never smoked, a BMI of 22.0 to 24.9 kg/m2 at age 18 years was associated with increased premature death (hazard ratio, 1.50).

Non-smokers with a BMI in this range should be counseled on potential health risks.

Overall low-carbohydrate-diet and low-fat-diet scores were not associated with total mortality.

Practitioners should consider that overall low-carb and low-fat diets may not impact mortality rates.

The rates of CVD and death are higher in men compared to women and in rural compared to urban areas.

Public health interventions should target men and rural populations to reduce CVD incidence.

The simultaneous target of low sodium intake (<2 g/day) with high potassium intake (>3.5 g/day) is extremely uncommon.

Practitioners should note the difficulty in achieving both low sodium and high potassium intakes in dietary practices.

Participants with diabetes were at higher risk of all-cause and CVD mortality and CVD incidence.

Healthcare providers should monitor diabetes patients closely for CVD and mortality risks.